Vani Sundaraiyer Selected Research

Erythema

8/2015

Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vani Sundaraiyer Research Topics

Disease

5	Pneumococcal Infections 11/2022 - 02/2015
2	Fever (Fevers) 01/2017 - 08/2015
1	Human Influenza (Influenza) 01/2019
1	Pneumonia (Pneumonitis) 01/2017
1	Tetanus 01/2017
1	Whooping Cough (Pertussis) 01/2017
1	Erythema 08/2015
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 08/2015
1	Guillain-Barre Syndrome 08/2015
1	Cellulitis 08/2015

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 01/2019 - 02/2015
3	Conjugate VaccinesIBA 11/2022 - 01/2017
1	AntipyreticsIBA 01/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017
1	AntigensIBA 01/2017
1	Hemagglutinins (Hemagglutinin)IBA 01/2017
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2017
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2017
1	23-valent pneumococcal capsular polysaccharide vaccineIBA 08/2015